1. Home
  2. OCUL vs MFA Comparison

OCUL vs MFA Comparison

Compare OCUL & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • MFA
  • Stock Information
  • Founded
  • OCUL 2006
  • MFA 1997
  • Country
  • OCUL United States
  • MFA United States
  • Employees
  • OCUL N/A
  • MFA N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • MFA Real Estate Investment Trusts
  • Sector
  • OCUL Health Care
  • MFA Real Estate
  • Exchange
  • OCUL Nasdaq
  • MFA Nasdaq
  • Market Cap
  • OCUL 957.3M
  • MFA 1.1B
  • IPO Year
  • OCUL 2014
  • MFA N/A
  • Fundamental
  • Price
  • OCUL $7.45
  • MFA $9.46
  • Analyst Decision
  • OCUL Strong Buy
  • MFA Buy
  • Analyst Count
  • OCUL 10
  • MFA 5
  • Target Price
  • OCUL $16.11
  • MFA $13.00
  • AVG Volume (30 Days)
  • OCUL 1.6M
  • MFA 1.7M
  • Earning Date
  • OCUL 05-05-2025
  • MFA 05-06-2025
  • Dividend Yield
  • OCUL N/A
  • MFA 15.22%
  • EPS Growth
  • OCUL N/A
  • MFA N/A
  • EPS
  • OCUL N/A
  • MFA 0.99
  • Revenue
  • OCUL $59,647,000.00
  • MFA $292,245,000.00
  • Revenue This Year
  • OCUL $13.32
  • MFA N/A
  • Revenue Next Year
  • OCUL $13.13
  • MFA $7.48
  • P/E Ratio
  • OCUL N/A
  • MFA $9.55
  • Revenue Growth
  • OCUL N/A
  • MFA 52.95
  • 52 Week Low
  • OCUL $4.06
  • MFA $7.85
  • 52 Week High
  • OCUL $11.78
  • MFA $13.45
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 48.17
  • MFA 47.31
  • Support Level
  • OCUL $8.07
  • MFA $9.32
  • Resistance Level
  • OCUL $8.90
  • MFA $10.03
  • Average True Range (ATR)
  • OCUL 0.48
  • MFA 0.26
  • MACD
  • OCUL -0.08
  • MFA 0.06
  • Stochastic Oscillator
  • OCUL 29.68
  • MFA 58.70

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About MFA MFA Financial Inc.

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company is an internally managed real estate investment trust or REIT.

Share on Social Networks: